Investigational Drug Information for Dihydrexidine
✉ Email this page to a colleague
What is the drug development status for Dihydrexidine?
Dihydrexidine is an investigational drug.
There have been 3 clinical trials for Dihydrexidine.
The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2013.
The most common disease conditions in clinical trials are Schizotypal Personality Disorder, Personality Disorders, and Disease. The leading clinical trial sponsors are New York State Psychiatric Institute, National Institute on Drug Abuse (NIDA), and Larry J. Siever.
Summary for Dihydrexidine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 213 |
| WIPO Patent Applications | 144 |
| Japanese Patent Applications | 57 |
| Clinical Trial Progress | Phase 2 (2013-04-01) |
| Vendors | 0 |
Recent Clinical Trials for Dihydrexidine
| Title | Sponsor | Phase |
|---|---|---|
| A D1 Agonist For Working Memory | National Institute of Mental Health (NIMH) | Phase 2 |
| A D1 Agonist For Working Memory | New York State Psychiatric Institute | Phase 2 |
| A D1 Agonist For Working Memory | Antonia New | Phase 2 |
Clinical Trial Summary for Dihydrexidine
Top disease conditions for Dihydrexidine
Top clinical trial sponsors for Dihydrexidine
US Patents for Dihydrexidine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
